Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRACTION trial of tretinoin added to peginterferon alfa-2a and ribavirin in prior non-responder genotype 1 chronic hepatitis C
2006-005500-14Phase 2Completed
- Sponsor
- University Medical Center Mainz
- Start
- Apr 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in hepatitis C virus infection comparing Tretinoin + peginterferon alfa-2a + ribavirin with Peginterferon alfa-2a + ribavirin (2 arms). Primary endpoint: HCV viral kinetics parameter M delta. Started Apr 2007; status: completed.
02
Drugs
tretinoinpeginterferon alfa-2aribavirin
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2006-005500-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005500-14.